Kelly S. Perlewitz, MD

Areas of Focus: Blood Cancer, Breast Cancer, Cancer Chemotherapy, Colorectal Cancer, Thoracic Cancer
Accepting New Patients
1000 North Providence Drive, Suite 310
Newberg, OR 97132
815.2 miles away
Medical Groups & Affiliations
Providence Medical Group - Oregon
Speaks: English
map

Providence Cancer Institute - Newberg

1000 North Providence Drive, Suite 310, Newberg, OR 97132

Insurances Accepted

This information provides an overview of accepted insurance plan types for new patients. Coverage may vary by specific plan. Please verify with your insurance provider before visiting us for care. Established patients should call to verify insurance acceptance.

About Kelly S. Perlewitz

Dr. Perlewitz currently serves as the medical director of hematology/oncology at Providence Cancer Institute. >br/>
"I view myself as partner and advisor to my patients and their family members. I understand that a cancer diagnosis and treatment can be overwhelming, and I believe that it's my role to provide education and guidance so that every patient and their family may have an integral part in the decision-making process." - Kelly Perlewitz, M.D.

Medical School

University of Medicine and Dentistry of New Jersey
2004

Residency

Temple University School of Medicine
2007

Fellowship

Oregon Health & Science University School of Medicine
2010

Board Certifications
  • American Board of Internal Medicine, Hematology
  • American Board of Internal Medicine, Medical Oncology
Providence Cancer Institute - Newberg
1000 North Providence Drive, Suite 310
Newberg, OR 97132

Medical Groups & Affiliations
Providence Medical Group - Oregon

Affiliated Locations
Providence St. Vincent Medical Center
Providence Portland Medical Center
Providence Seaside Hospital
Providence Newberg Medical Center
Providence Willamette Falls Medical Center
Providence Hood River Memorial Hospital

Conditions and Procedures

  • Adrenal Neoplasm
  • Anal Cancer
  • Anemia
  • Anorectal Cancer
  • Antithrombin Deficiency
  • Atypical Ductal Hyperplasia
  • Bladder Cancer
  • Blood Cancer
  • Breast Cancer
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Pain
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoid Tumor
  • Carcinoma In Situ Of Breast
  • Carcinoma Of Unknown Primary
  • Chemoradiation
  • Chest Wall Tumors
  • Cholangiocarcinoma
  • Clinical Trials
  • Colon Cancer
  • Colorectal Cancer
  • Colorectal Metastases
  • Crizotinib
  • Ductal Carcinoma In Situ (Dcis)
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Erlotinib
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastrointestinal (Gi) Cancer
  • Head And Neck Cancer
  • Hereditary Breast And Ovarian Cancer
  • Hypopharyngeal Cancer
  • Kidney Cancer
  • Leukemia
  • Lobular Carcinoma In Situ (Lcis)
  • Lung Cancer
  • Lung Metastasis
  • Lymphedema Therapy
  • Lymphoma
  • Lynch Syndrome
  • Male Breast Cancer
  • Mediastinal Mass
  • Melanoma
  • Mesothelioma
  • Metastatic Liver Cancer
  • Metastatic Melanoma
  • Metastatic Tumors To The Lungs
  • Mouth Cancer
  • Multiple Myeloma
  • Neuroendocrine Tumors
  • Non Hodgkin Lymphoma
  • Non Small Cell Lung Cancer
  • Oropharyngeal Cancer
  • Pancreas Cancer
  • Prostate Cancer
  • Pulmonary Metastases
  • Side Effects Of Cancer Treatment
  • Skin Cancer
  • Small Bowel Cancer
  • Small Cell Lung Cancer
  • Stomach Cancer
  • Targeted Molecular Therapy
  • Testicular Cancer
  • Thoracic Cancer
  • Thymoma
  • Thyroid Cancer
  • Unknown Primary Cancer